Insider Trading Alert - WDC, ODP, TRLA, KLIC And UTHR Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Tuesday, Dec. 24, 2013, 63 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $3,759.88 to $2,069,942.45.

Highlighted Stocks Traded by Insiders:

Western Digital Corporation (WDC) - FREE Research Report

Cordano Michael D who is President, HGST Subsidiary at Western Digital Corporation sold 2,859 shares at $83.45 on Dec. 24, 2013. Following this transaction, the President, HGST Subsidiary owned 87,966 shares meaning that the stake was reduced by 3.15% with the 2,859-share transaction.

The shares most recently traded at $82.96, down $0.49, or 0.59% since the insider transaction. Historical insider transactions for Western Digital Corporation go as follows:

  • 4-Week # shares sold: 2,859
  • 12-Week # shares sold: 72,414
  • 24-Week # shares sold: 81,465

The average volume for Western Digital Corporation has been 2.2 million shares per day over the past 30 days. Western Digital Corporation has a market cap of $19.5 billion and is part of the technology sector and computer hardware industry. Shares are up 94.3% year-to-date as of the close of trading on Tuesday.

Western Digital Corporation, through its subsidiaries, develops, manufactures, and sells storage products and solutions that enable people to create, manage, experience, and preserve digital content. The stock currently has a dividend yield of 1.45%. The company has a P/E ratio of 20.8. Currently there are 8 analysts that rate Western Digital Corporation a buy, 1 analyst rates it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WDC - FREE

TheStreet Quant Ratings rates Western Digital Corporation as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Western Digital Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Office Depot (ODP) - FREE Research Report

Garcia C Elisa D who is EVP, General Counsel & Secy at Office Depot sold 41,064 shares at $5.31 on Dec. 24, 2013. Following this transaction, the EVP, General Counsel & Secy owned 370,812 shares meaning that the stake was reduced by 9.97% with the 41,064-share transaction.

The shares most recently traded at $5.35, up $0.04, or 0.67% since the insider transaction. Historical insider transactions for Office Depot go as follows:

  • 4-Week # shares bought: 35,587
  • 4-Week # shares sold: 72,437
  • 12-Week # shares bought: 35,587
  • 12-Week # shares sold: 276,735
  • 24-Week # shares bought: 49,758
  • 24-Week # shares sold: 276,735

The average volume for Office Depot has been 10.6 million shares per day over the past 30 days. Office Depot has a market cap of $1.6 billion and is part of the services sector and specialty retail industry. Shares are up 64.02% year-to-date as of the close of trading on Tuesday.

Office Depot, Inc., together with its subsidiaries, supplies office products and services. The company has a P/E ratio of 44.8. Currently there are 4 analysts that rate Office Depot a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ODP - FREE

TheStreet Quant Ratings rates Office Depot as a hold. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, impressive record of earnings per share growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including poor profit margins and weak operating cash flow. Get the full Office Depot Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Trulia (TRLA) - FREE Research Report

Inkinen Sami who is Director at Trulia sold 5,800 shares at $33.97 on Dec. 24, 2013. Following this transaction, the Director owned 879,753 shares meaning that the stake was reduced by 0.65% with the 5,800-share transaction.

Flint Peter who is Chief Executive Officer at Trulia sold 9,200 shares at $34.00 on Dec. 24, 2013. Following this transaction, the Chief Executive Officer owned 1.4 million shares meaning that the stake was reduced by 0.65% with the 9,200-share transaction.

The shares most recently traded at $34.48, up $0.48, or 1.4% since the insider transaction. Historical insider transactions for Trulia go as follows:

  • 4-Week # shares sold: 63,623
  • 12-Week # shares sold: 209,985
  • 24-Week # shares sold: 416,179

The average volume for Trulia has been 1.4 million shares per day over the past 30 days. Trulia has a market cap of $1.3 billion and is part of the technology sector and internet industry. Shares are up 113.24% year-to-date as of the close of trading on Tuesday.

Trulia, Inc. provides tools to research homes and neighborhoods for consumers through Web and mobile applications. The company, through its tools, also enables real estate professionals to market their listings. The company has a P/E ratio of 230.9. Currently there are 3 analysts that rate Trulia a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on TRLA - FREE

TheStreet Quant Ratings rates Trulia as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that net income has been generally deteriorating over time. Get the full Trulia Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Kulicke & Soffa Industries (KLIC) - FREE Research Report

Guilmart Bruno who is President, CEO at Kulicke & Soffa Industries sold 50,000 shares at $13.00 on Dec. 24, 2013. Following this transaction, the President, CEO owned 617,540 shares meaning that the stake was reduced by 7.49% with the 50,000-share transaction.

Wong Nelson MunPun who is Vice President at Kulicke & Soffa Industries sold 10,000 shares at $13.00 on Dec. 24, 2013. Following this transaction, the Vice President owned 35,604 shares meaning that the stake was reduced by 21.93% with the 10,000-share transaction.

The shares most recently traded at $13.05, up $0.05, or 0.38% since the insider transaction. Historical insider transactions for Kulicke & Soffa Industries go as follows:

  • 4-Week # shares sold: 120,000
  • 12-Week # shares sold: 159,706
  • 24-Week # shares sold: 239,323

The average volume for Kulicke & Soffa Industries has been 888,800 shares per day over the past 30 days. Kulicke & Soffa Industries has a market cap of $995.2 million and is part of the technology sector and electronics industry. Shares are up 9.26% year-to-date as of the close of trading on Tuesday.

Kulicke and Soffa Industries, Inc. designs, manufactures, and sells capital equipment and expendable tools to assemble semiconductor devices, including integrated circuits, discrete devices, light-emitting diodes, and power modules. The company has a P/E ratio of 16.8. Currently there are 2 analysts that rate Kulicke & Soffa Industries a buy, 1 analyst rates it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KLIC - FREE

TheStreet Quant Ratings rates Kulicke & Soffa Industries as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full Kulicke & Soffa Industries Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

United Therapeutics Corporation (UTHR) - FREE Research Report

Rothblatt Martine A who is Ceo at United Therapeutics Corporation sold 18,149 shares at $114.05 on Dec. 24, 2013. Following this transaction, the Ceo owned 605,676 shares meaning that the stake was reduced by 2.91% with the 18,149-share transaction.

The shares most recently traded at $112.03, down $2.02, or 1.81% since the insider transaction. Historical insider transactions for United Therapeutics Corporation go as follows:

  • 24-Week # shares sold: 1,000

The average volume for United Therapeutics Corporation has been 677,400 shares per day over the past 30 days. United Therapeutics Corporation has a market cap of $5.7 billion and is part of the health care sector and drugs industry. Shares are up 111.25% year-to-date as of the close of trading on Tuesday.

United Therapeutics Corporation, a biotechnology company, focuses on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. The company has a P/E ratio of 20.5. Currently there are 4 analysts that rate United Therapeutics Corporation a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UTHR - FREE

TheStreet Quant Ratings rates United Therapeutics Corporation as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, solid stock price performance and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full United Therapeutics Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Asian Markets Decline in Morning Trading

Asian Markets Decline in Morning Trading

Verizon Proves Resilient in Sell-Off; Decoding the Facebook Short -- ICYMI

Verizon Proves Resilient in Sell-Off; Decoding the Facebook Short -- ICYMI

Three Big Factors That Rocked the Stock Market Tuesday

Three Big Factors That Rocked the Stock Market Tuesday

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call